Patent · US Active

2-{[2-(substituted amino)ethyl]sulfonyl}ethyl N,N-bis(2-chloroethyl)phosphorodiamidates

US7872134B2 · kind B2 · utility

0Cited by

3References

13Claims

0Family size

Assignee

Telik, Inc. · US

Inventors

Edgardo Laborde · Canton, US
Andrew B. Kelson · Redwood City, US
Wenli Ma · Union City, US
Kevin T. Weber · Fremont, US

Key dates

Filing date	Dec 12, 2007
Grant date	Jan 18, 2011
Priority date	—
Expiry date	Jul 3, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07F9/2408
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

2-{[2-(Substituted amino)ethyl]sulfonyl}ethyl N,N-bis(2-chloroethyl)phosphorodiamidates and their salts, their preparation and intermediates in their preparation, pharmaceutical compositions containing them, and methods of treatment using them. The compounds are useful for treating cancer and autoimmune diseases, alone and in combination with other therapies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.